These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy. Stolz D; Christ-Crain M; Bingisser R; Leuppi J; Miedinger D; Müller C; Huber P; Müller B; Tamm M Chest; 2007 Jan; 131(1):9-19. PubMed ID: 17218551 [TBL] [Abstract][Full Text] [Related]
6. Antibiotics for treatment and prevention of exacerbations of chronic obstructive pulmonary disease. Wilson R; Sethi S; Anzueto A; Miravitlles M J Infect; 2013 Dec; 67(6):497-515. PubMed ID: 23973659 [TBL] [Abstract][Full Text] [Related]
7. Predictors of treatment with antibiotics and systemic corticosteroids for acute exacerbations of asthma and chronic obstructive pulmonary disease in primary care. Salwan AA; Spigt M; Laue J; Melbye H BMC Fam Pract; 2015 Mar; 16():40. PubMed ID: 25887285 [TBL] [Abstract][Full Text] [Related]
8. Antibiotic therapy for exacerbations of chronic obstructive pulmonary disease (COPD). Butorac-Petanjek B; Parnham MJ; Popovic-Grle S J Chemother; 2010 Oct; 22(5):291-7. PubMed ID: 21123150 [TBL] [Abstract][Full Text] [Related]
9. β-Lactam plus aminoglycoside or fluoroquinolone combination versus β-lactam monotherapy for Pseudomonas aeruginosa infections: a meta-analysis. Vardakas KZ; Tansarli GS; Bliziotis IA; Falagas ME Int J Antimicrob Agents; 2013 Apr; 41(4):301-10. PubMed ID: 23410791 [TBL] [Abstract][Full Text] [Related]
10. C-Reactive Protein Testing to Guide Antibiotic Prescribing for COPD Exacerbations. Butler CC; Gillespie D; White P; Bates J; Lowe R; Thomas-Jones E; Wootton M; Hood K; Phillips R; Melbye H; Llor C; Cals JWL; Naik G; Kirby N; Gal M; Riga E; Francis NA N Engl J Med; 2019 Jul; 381(2):111-120. PubMed ID: 31291514 [TBL] [Abstract][Full Text] [Related]
11. CRP-guided antibiotic treatment in acute exacerbations of COPD in hospital admissions. Prins HJ; Duijkers R; van der Valk P; Schoorl M; Daniels JMA; van der Werf TS; Boersma WG Eur Respir J; 2019 May; 53(5):. PubMed ID: 30880285 [TBL] [Abstract][Full Text] [Related]
13. General practitioner use of a C-reactive protein point-of-care test to help target antibiotic prescribing in patients with acute exacerbations of chronic obstructive pulmonary disease (the PACE study): study protocol for a randomised controlled trial. Bates J; Francis NA; White P; Gillespie D; Thomas-Jones E; Breen R; Kirby N; Hood K; Gal M; Phillips R; Naik G; Cals J; Llor C; Melbye H; Wootton M; Riga E; Cochrane A; Howe R; Fitzsimmons D; Sewell B; Alam MF; Butler CC Trials; 2017 Sep; 18(1):442. PubMed ID: 28969667 [TBL] [Abstract][Full Text] [Related]
14. Chronic Obstructive Pulmonary Disease in the Intensive Care Unit: Antibiotic Treatment of Severe Chronic Obstructive Pulmonary Disease Exacerbations. Gupta N; Haley R; Gupta A; Sethi S Semin Respir Crit Care Med; 2020 Dec; 41(6):830-841. PubMed ID: 32781475 [TBL] [Abstract][Full Text] [Related]
15. Newer fluoroquinolones in the treatment of acute exacerbations of COPD. Patel A; Wilson R Int J Chron Obstruct Pulmon Dis; 2006; 1(3):243-50. PubMed ID: 18046861 [TBL] [Abstract][Full Text] [Related]
16. Chronic Respiratory Infection in Patients with Chronic Obstructive Pulmonary Disease: What Is the Role of Antibiotics? Miravitlles M; Anzueto A Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28644389 [TBL] [Abstract][Full Text] [Related]
17. Is fluoroquinolone monotherapy a useful alternative treatment for Pseudomonas aeruginosa bacteraemia? Wu PF; Lin YT; Wang FD; Yang TC; Fung CP Infection; 2018 Jun; 46(3):365-373. PubMed ID: 29556979 [TBL] [Abstract][Full Text] [Related]
18. The benefits of long-term systemic antimicrobial therapy in chronic obstructive pulmonary disease. Berim I; Sethi S Ther Adv Respir Dis; 2011 Jun; 5(3):207-16. PubMed ID: 21378062 [TBL] [Abstract][Full Text] [Related]
19. Combination antimicrobial susceptibility testing for acute exacerbations in chronic infection of Pseudomonas aeruginosa in cystic fibrosis. Waters V; Ratjen F Cochrane Database Syst Rev; 2015 Nov; (11):CD006961. PubMed ID: 26522473 [TBL] [Abstract][Full Text] [Related]
20. Combination antimicrobial susceptibility testing for acute exacerbations in chronic infection of Pseudomonas aeruginosa in cystic fibrosis. Smith S; Ratjen F; Remmington T; Waters V Cochrane Database Syst Rev; 2020 May; 5(5):CD006961. PubMed ID: 32412092 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]